BCIM
JAZZ icon

British Columbia Investment Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

British Columbia Investment Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-7,103
Closed -$855K – 758
2024
Q1 		$855K Buy
7,103
+197
+3% +$24.1K 0.01% 744
2023
Q4 		$849K Buy
6,906
+1,074
+18% +$134K 0.01% 729
2023
Q3 		$755K Buy
5,832
+226
+4% +$30.1K 0.01% 700
2023
Q2 		$695K Hold
5,606
– – 0.01% 730
2023
Q1 		$820K Buy
5,606
+119
+2% +$17.6K 0.01% 691
2022
Q4 		$874K Sell
5,487
-681
-11% -$99.8K 0.01% 659
2022
Q3 		$822K Sell
6,168
-939
-13% -$143K 0.01% 692
2022
Q2 		$1.11M Sell
7,107
-2,382
-25% -$367K 0.01% 676
2022
Q1 		$1.48M Sell
9,489
-1,299
-12% -$189K 0.01% 714
2021
Q4 		$1.37M Sell
10,788
-461
-4% -$60.6K 0.01% 768
2021
Q3 		$1.47M Hold
11,249
– – 0.01% 760
2021
Q2 		$2M Buy
11,249
+2,101
+23% +$364K 0.01% 712
2021
Q1 		$1.5M Sell
9,148
-220
-2% -$36.2K 0.01% 725
2020
Q4 		$1.55M Sell
9,368
-227
-2% -$33.8K 0.01% 709
2020
Q3 		$1.37M Buy
9,595
+600
+7% +$74.4K 0.01% 688
2020
Q2 		$993K Buy
8,995
+2,805
+45% +$310K 0.01% 723
2020
Q1 		$617K Sell
6,190
-7,151
-54% -$925K 0.01% 683
2019
Q4 		$1.99M Sell
13,341
-61,383
-82% -$8.35M 0.01% 676
2019
Q3 		$9.57M Buy
74,724
+20,311
+37% +$2.72M 0.09% 225
2019
Q2 		$7.76M Buy
54,413
+37,975
+231% +$5.1M 0.07% 306
2019
Q1 		$2.35M Sell
16,438
-4,040
-20% -$527K 0.02% 630
2018
Q4 		$2.54M Buy
20,478
+2,028
+11% +$301K 0.02% 617
2018
Q3 		$3.1M Sell
18,450
-6,721
-27% -$1.16M 0.03% 510
2018
Q2 		$4.34M Buy
25,171
+2,629
+12% +$430K 0.04% 490
2018
Q1 		$3.4M Sell
22,542
-1,395
-6% -$205K 0.03% 582
2017
Q4 		$3.22M Sell
23,937
-5,122
-18% -$710K 0.02% 599
2017
Q3 		$4.25M Buy
29,059
+5,844
+25% +$884K 0.03% 511
2017
Q2 		$3.61M Sell
23,215
-4,021
-15% -$615K 0.03% 549
2017
Q1 		$3.95M Buy
27,236
+1,487
+6% +$194K 0.03% 528
2016
Q4 		$2.81M Sell
25,749
-5,413
-17% -$603K 0.02% 587
2016
Q3 		$3.79M Sell
31,162
-1,565
-5% -$211K 0.04% 511
2016
Q2 		$4.63M Buy
32,727
+2,637
+9% +$389K 0.04% 469
2016
Q1 		$3.93M Sell
30,090
-5,941
-16% -$740K 0.04% 504
2015
Q4 		$5.07M Buy
36,031
+21,406
+146% +$2.97M 0.05% 435
2015
Q3 		$1.94M Buy
14,625
+6,136
+72% +$1.06M 0.02% 548
2015
Q2 		$1.5M Sell
8,489
-1,314
-13% -$236K 0.01% 634
2015
Q1 		$1.69M Buy
9,803
+4,037
+70% +$693K 0.02% 605
2014
Q4 		$944K Buy
+5,766
New +$957K 0.01% 635

Other funds holding JAZZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
PCM
Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return

British Columbia Investment Management's JAZZ Position: Q2 2024 in Review

British Columbia Investment Management sold out of Jazz Pharmaceuticals (JAZZ) in Q2 2024, closing a stake of 7,103 shares — an estimated $855K sold.

British Columbia Investment Management first reported a position in JAZZ in Q4 2014 and held it in 38 quarters. The position peaked at $9.57M in Q3 2019. 455 funds tracked by Wall St. Rank hold JAZZ as of Q2 2024.

  • British Columbia Investment Management reported no remaining Jazz Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • British Columbia Investment Management sold 7,103 Jazz Pharmaceuticals shares in Q2 2024, an estimated $855K.
  • British Columbia Investment Management first reported a position in Jazz Pharmaceuticals in Q4 2014 and held it in 38 quarters.
  • British Columbia Investment Management's Jazz Pharmaceuticals position peaked at $9.57M in Q3 2019.
  • 455 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2024.

Based on British Columbia Investment Management's 13F filing for Q2 2024, filed 14 Aug 2024.